Credits: 1.00
Fee: None
Sponser: Medscape
Expiration Date: May 30, 2004
Multimedia Content: None
Notes: This activity differentiates between urinary stress incontinence, urge incontinence, and mixed incontinence, identifies the causes of stress urinary incontinence, and describes the various treatment options for stress incontinence for women of all ages. The course also reviews the epidemiology and pathophysiology of stress urinary incontinence. |
Credits: 2.25
Fee: None
Sponser: Meniscus Educational Institute
Expiration Date: April 24, 2004
Multimedia Content: Audio
Notes: There are five audio presentations that make up this activity, including “Quantitating Immunologic Response to Vaccines Targeting Cancer,” presented by H. Kim Lyerly, MD, and “MUC-1-Based Vaccine Strategies in Advanced Breast Cancer,” presented by David W. Miles, MD. Participants may also download from this site a supplemental workbook containing all of the slides referenced during the presentations. Collectively, the lectures describe advances in immunotherapies in the treatment of breast cancer, identify phenotypic and functional assays available for quantitating immune responses to cancer vaccines, and examine the potential applications of genetic profiling in breast cancer diagnosis and treatment. |
Credits: 1.50
Fee: None
Sponser: Medical Education Resources
Expiration Date: March 1, 2005
Multimedia Content: None
Notes: This activity describes the causes of and conditions associated with cancer pain, discusses intercostobrachial neuralgia as a complication of breast cancer treatment, identifies useful methods of diagnosing specific painful complications of cancer, evaluates pharmacologic, therapeutic, and toxicologic principles involved in relieving cancer pain, and defines specific terms that describe elements of cancer pain and its control. |
Credits: 2.00
Fee: None
Sponser: The Postgraduate Institute for Medicine
Expiration Date: June 26, 2004
Multimedia Content: None
Notes: There are four components to this CME program: “Pathophysiology of Cancer Treatment-Induced Bone Loss,” “Role of Bisphosphonates in Men With Prostate Cancer Receiving Androgen Deprivation Therapy,” “Hormone- and Chemotherapy-Induced Bone Loss in Women With Breast Cancer,” and “New-Generation Bisphosphonates Have Broad Clinical Utility Across the Continuum of Care for Breast and Prostate Cancer.” The program is designed to educate medical oncologists, urologists, and oncology nurses involved in the treatment and management of cancer treatment-induced bone loss. |
Credits: 3.00
Fee: Not Listed
Sponser: American Medical Association
Expiration Date: May 2004
Multimedia Content: None
Notes: Complete this activity and acquire information that will guide you in the appropriate use of genetic testing to identify patients with an inherited risk for HNPCC. Topics covered include the genes responsible for HNPCC, the association between MLH1 and MSH2 gene mutations and the risk for HNPCC, interpretation of test results, medical management options for individuals with HNPCC gene mutations, including those with cancer, and pre- and post-test patient counseling. |
Credits: 3.00
Fee: Not Listed
Sponser: American Medical Association
Expiration Date: October 2003
Multimedia Content: None
Notes: To enhance your ability to identify patients at risk for hereditary breast and ovarian cancer, complete this activity and associated post-test and evaluation. Subjects discussed include the genes responsible for hereditary breast and ovarian cancer, the association between BRCA mutations and the risk for hereditary breast and ovarian cancer, treatment options for women with BRCA1 and BRCA2 mutations, including women diagnosed with breast cancer, and the benefits and limitations of genetic testing for hereditary risk of breast and ovarian cancer. |
Credits: 1.00
Fee: None
Sponser: University of Texas Health Science Center at San Antonio Medical School
Expiration Date: December 31, 2003
Multimedia Content: Audio/Video
Notes: This activity consists of two presentations drawn from material originally presented at the Sixth Annual Conference of the National Hispanic Medical Association. “Disparities in Pain Management: Will This Legacy Continue” reviews the published medical literature on pain management disparities related to ethnicity and race, and describes intervention models that address racial and ethnic patient-doctor communication and concerns with pain medications. “Taming the Fire and Misconceptions of Pain” evaluates the myths, misconceptions, and misunderstandings of treating pain in the Hispanic patient, discusses pain management protocols that deliver effective and continuous pain relief, and examines the adequacy and inadequacy of certain prescribed analgesics and their potential advantages and disadvantages. |
Credits: 1.00
Fee: None
Sponser: Medscape
Expiration Date: May 30, 2004
Multimedia Content: None
Notes: Medscape offers this course that examines recent developments in the management of patients with chronic lymphocytic leukemia (CLL). Successfully completing this activity will provide physicians with a greater understanding of the treatment regimens for CLL that have been used over the past few decades, the reasons why newer regimens and agents are needed, and the ways in which humanized monoclonal antibodies can improve treatment outcomes. |
Credits: 1.25
Fee: Not Listed
Sponser: HMP Communications
Expiration Date: September 12, 2003
Multimedia Content: Audio
Notes: This audio program features a panel of experts discussing the use of monoclonal antibody therapy in the treatment of non-Hodgkin’s lymphoma and chronic lymphocytic leukemia, including single agents, combination therapy, dosing, and scheduling. |
Credits: 1.00
Fee: None
Sponser: Medscape
Expiration Date: June 23, 2004
Multimedia Content: None
Notes: Topics covered by this online CME course include the epidemiology of non-Hodgkin’s lymphoma (NHL), the clinical evaluation and staging of patients with NHL, prognostic factors, new treatment strategies, conjugated and unconjugated monoclonal antibodies, and nonmyeloablative allogeneic stem-cell transplantation. |
Credits: 1.00
Fee: None
Sponser: Medical Education Collaborative
Expiration Date: April 30, 2004
Multimedia Content: None
Notes: This article addresses topics in first- and second-line therapy, the role of surgical intervention in medical management, and future directions for treatment research. Completing the reading and post-test will provide participating physicians with a better understanding of ways to maximize first-line therapy, including intraperitoneal chemotherapy, maintenance therapy, and additions to standard combination regimens, and differing approaches to relapsed or metastatic ovarian cancer, including monotherapy, combination therapy, surgical approaches, novel targeted agents, and quality-of-life considerations. |
Credits: 2.50
Fee: None
Sponser: Tufts University School of Medicine
Expiration Date: June 13, 2004
Multimedia Content: Flash Animation/Audio
Notes: Among the six excellent presentations collected in this exercise, you will find Dr. Heinz-Josef Lenz’s tour de force on proteasome inhibitors in small tumors, Dr. Paul Richardson’s survey of the results of the Phase II SUMMIT Trial, and the showstopper that still has his fellow conference-goers talking, Dr. David Schenkein’s “Proteasome Inhibition as a Therapy for Multiple Myeloma: Future Directions and Closing Remarks.” Complete this program and you will come away with a better understanding of the structure and function of the proteasome, the preclinical rationale for proteasome inhibition as a potential therapy for cancer, and emerging clinical data on this promising class of agents. |
Credits: 2.00
Fee: None
Sponser: University of Wisconsin Medical School
Expiration Date: June 25, 2004
Multimedia Content: Flash Animation/Audio
Notes: The three lectures that make up this activity, “The Incidence and Prevalence of Stress Urinary Incontinence,” “The Impact of Stress Urinary Incontinence on Quality of Life,” and “Clinical Applications: Current Treatments for Stress Urinary Incontinence,” were first presented at the “Stress Urinary Incontinence: Expanding the Treatment Options” symposium held April 25, 2003. The material covers the current epidemiologic data on the incidence and prevalence of stress urinary incontinence, the impact of stress urinary incontinence on quality-of-life, the role of the central nervous system and neurotransmitters in lower urinary tract control, and current treatment approaches for stress urinary incontinence, including conservative, pharmacological, and surgical treatments. |
Credits: 1.00
Fee: None
Sponser: Medical Education Collaborative
Expiration Date: May 30, 2004
Multimedia Content: None
Notes: Edgardo Rivera, MD, discusses chemotherapy and hormonal treatment options for metastatic breast cancer in the aptly titled “Metastatic Breast Cancer,” and Robert A. Bulger, MD, addresses the treatment of ovarian cancer and quality-of-life issues in “Metastatic Ovarian Cancer.” Physicians completing this activity will possess a greater understanding of the distinctions between the goals of treatment for early- and late-stage cancer, the common side effects of the standard chemotherapy regimens used in the treatment of breast and ovarian cancer, and their impact on quality-of-life parameters, and treatment strategies that can minimize side effects and improve patients’ quality of life. |
|
 |
Departments
Internet Listings
|
